. . . . . . . . . . . "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting"@en . . . . . . . . "scientific article published on 02 February 2019"@en . "Friedrich Rippmann" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u044E\u0442\u043E\u043C\u0443 2019"@uk . "Avoiding hERG-liability in drug design via synergetic combinations of different"@nl . . . . . . "article scientifique publi\u00E9 en 2019"@fr . . "Fabian P Steinmetz" . . . . . . . . . . . . . . . . . "11" . . . . . . . . . . "Avoiding hERG-liability in drug design via synergetic combinations of different"@nl . "wetenschappelijk artikel"@nl . . . . . "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting"@en . "2019-02-02T00:00:00Z"^^ . . . "6689868" . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en febreru de 2019"@ast . . . . . . . . . . . . . . . . "30712151" . . . "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting"@en . "1111893688" . "journals/jcheminf/HanserSPRK19" . "1" . . . . . . . . . . . "10.1186/S13321-019-0334-Y" . "9" . . . . . . . . . . "Avoiding hERG-liability in drug design via synergetic combinations of different"@nl . "im Februar 2019 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . "Thierry Hanser" . . . . . . . "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting"@en . . . "Mireille Krier" . . . . .